Video
Webinar: The Ongoing Impact of COVID-19 on New Product Launches and Cancer Care
On-Demand Webinar
Jul 01, 2021

IQVIA experts explore the ongoing impact of COVID-19 on European pharmaceutical markets, including unique insights from HCPs on the prescription of newly launched products as well as a renewed focus on the continued impact of COVID-19 on cancer care, with new learnings from IQVIA’s Oncology Dynamics Team.


Gain new insights into:
  • COVID-19’s impact on HCP’s intent-to-prescribe newly launched pharmaceutical products
  • Oncology patient care in times of COVID-19 – a comparative analysis pre-pandemic vs. present
  • How HCP engagement patterns changed during the pandemic

IQVIA Speakers:

Sarah Rickwood, VP, European Thought Leadership & Marketing

Caroline Anger, Associate Director, Global Oncology Offering Development

Dr Nicole Friedersdorf, Global Oncology Associate Product & Strategy Director.

The Ongoing Impact of COVID-19 on New Product Launches and Cancer Care
Contact Us